BLACK WEEKSHætteglas −15% · kits −10% · resten −5%med kodeGratis fragt i Tyskland fra €200

Denne side er oversat automatisk og kan indeholde fejl. Har du dansk som modersmål? Vi hører meget gerne din feedback og dine rettelser.Send feedback

The Peptide Desk The Peptide Desk
Dutasteride, produktfoto

Laboratorierapport

PDF
Testet
Testet
Dutasteride 1mg × 100 Tabs
Laboratorium
Analiza Białek
Dato
October 2026
Resultat
1.02 mg per tablet (1 mg label)
Ordrenr.
Adgangskode

Uafhængigt testet, kan verificeres med adgangskoden direkte hos laboratoriet.

Hair & Skin

Dutasteride

Hair & Skin

Bestilling

Stykpris - Gratis fragt i Tyskland fra 200 € under Black Weeks
  • DHL med sporing
  • Diskret emballage

4.6 ud af 5 på Trustpilot73 anmeldelser

Søges også som: Dutasterid

Kort fortalt

Dutasteride i tal

Nøgletallene fra vores leksikon. Træk punktet langs kurven for at se, hvor meget der er tilbage efter én dosis, beregnet.

Hele leksikonopslaget

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~5 weeks

Half-life ~5 weeks
After 10 weeks: 25 %
Week 550 %Week 1025 %Week 1512.5 %Week 253.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

about5weeks

Class
5α-reductase inhibitor type 1 and type 2
Use
Oral1 tablet per day or every other day
Sizes
1 mg1 size in the shop

Viden

Alt om Dutasteride

FAQ

Ofte stillede spørgsmål

Kilder til hvert svar: leksikonopslag

Har du stadig et spørgsmål?

Skriv til os, vores team hjælper dig.

Is dutasteride approved?

Yes. In the USA it has been approved as a prescription drug for the enlarged prostate since 20 November 2001, ChEMBL lists phase 4 as the highest phase. In hereditary hair loss it is used outside this approval, there are phase 3 trials on this.

How does dutasteride differ from finasteride?

Finasteride blocks only 5-alpha reductase type 2, dutasteride both types. In a comparison trial in men with enlarged prostate blood DHT fell by 94.7 percent with the approved dose of dutasteride and by 70.8 percent with finasteride. With finasteride the values also varied much more.

What do the hair loss trials show?

The first trial with 416 men already showed more hair in a dose-dependent way, the highest dose beat finasteride. In a trial with 917 men the approved dose grew more and thicker hairs after 24 weeks than finasteride and placebo. In a Korean phase 3 trial hair count rose by 12.2 per square centimetre in 6 months, on placebo by 4.7. All trials lasted at most 6 months.

What does research show for the prostate?

In three identical trials with 4,325 men the prostate shrank by 25.7 percent in 24 months, symptoms fell by 21.4 percent and urine flow rose. The risk of acute urinary retention fell by 57 percent, of surgery by 48 percent. In the CombAT trial the combination with tamsulosin worked better on symptoms over 4 years than either drug alone.

Does dutasteride lower prostate cancer risk?

In the 4-year REDUCE trial prostate cancer was found less often on dutasteride, 22.8 percent less in relative terms. Aggressive tumours with Gleason 8 to 10, however, were more common in years 3 and 4, 12 against 1. The composite term heart failure was also more common at 0.7 against 0.4 percent.

Which side effects have been described?

In the prostate trials impotence, reduced libido, breast enlargement and ejaculation disorders occurred more often than on placebo, but rarely overall. Except for breast enlargement they became less frequent over time. A meta-analysis in hair loss found a 1.37-fold risk of sexual side effects for dutasteride, not statistically significant. In direct comparison with finasteride there was no clear difference.

Sammenligninger

Sådan klarer den sig

Relateret

Relaterede produkter